153 related articles for article (PubMed ID: 23653048)
61. Lentivirus-mediated knockdown of eukaryotic translation initiation factor 3 subunit D inhibits proliferation of HCT116 colon cancer cells.
Yu X; Zheng B; Chai R
Biosci Rep; 2014 Dec; 34(6):e00161. PubMed ID: 25370813
[TBL] [Abstract][Full Text] [Related]
62. Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.
Sanada M; Hidaka M; Takagi Y; Takano TY; Nakatsu Y; Tsuzuki T; Sekiguchi M
Carcinogenesis; 2007 Dec; 28(12):2657-63. PubMed ID: 17881774
[TBL] [Abstract][Full Text] [Related]
63. Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells.
Kuang J; Wang YL; Xiao M; Tang Y; Chen WW; Song GL; Yang X; Li M
Oncol Rep; 2014 May; 31(5):2335-43. PubMed ID: 24676941
[TBL] [Abstract][Full Text] [Related]
64. Proliferation rate but not mismatch repair affects the long-term response of colon carcinoma cells to 5FU treatment.
Choudhary B; Hanski ML; Zeitz M; Hanski C
Cancer Lett; 2012 Jul; 320(1):56-64. PubMed ID: 22266192
[TBL] [Abstract][Full Text] [Related]
65. Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.
Plumb JA; Strathdee G; Sludden J; Kaye SB; Brown R
Cancer Res; 2000 Nov; 60(21):6039-44. PubMed ID: 11085525
[TBL] [Abstract][Full Text] [Related]
66. Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status.
Petitprez A; Poindessous V; Ouaret D; Regairaz M; Bastian G; Guérin E; Escargueil AE; Larsen AK
Int J Oncol; 2013 May; 42(5):1644-53. PubMed ID: 23546019
[TBL] [Abstract][Full Text] [Related]
67. New insights into PARP inhibitors' effect on cell cycle and homology-directed DNA damage repair.
Jelinic P; Levine DA
Mol Cancer Ther; 2014 Jun; 13(6):1645-54. PubMed ID: 24694947
[TBL] [Abstract][Full Text] [Related]
68. MLH1 deficiency enhances tumor cell sensitivity to ganciclovir.
O'Konek JJ; Boucher PD; Iacco AA; Wilson TE; Shewach DS
Cancer Gene Ther; 2009 Sep; 16(9):683-92. PubMed ID: 19300472
[TBL] [Abstract][Full Text] [Related]
69. MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro.
Imesch P; Goerens A; Fink D; Fedier A
Oncol Lett; 2012 Feb; 3(2):441-444. PubMed ID: 22740928
[TBL] [Abstract][Full Text] [Related]
70. Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11.
Rodriguez R; Hansen LT; Phear G; Scorah J; Spang-Thomsen M; Cox A; Helleday T; Meuth M
Clin Cancer Res; 2008 Sep; 14(17):5476-83. PubMed ID: 18765539
[TBL] [Abstract][Full Text] [Related]
71. Altered expression of cell proliferation-related and interferon-stimulated genes in colon cancer cells resistant to SN38.
Gongora C; Candeil L; Vezzio N; Copois V; Denis V; Breil C; Molina F; Fraslon C; Conseiller E; Pau B; Martineau P; Del Rio M
Cancer Biol Ther; 2008 Jun; 7(6):822-32. PubMed ID: 18340113
[TBL] [Abstract][Full Text] [Related]
72. In vitro and in vivo enhancement of chemoradiation using the oral PARP inhibitor ABT-888 in colorectal cancer cells.
Shelton JW; Waxweiler TV; Landry J; Gao H; Xu Y; Wang L; El-Rayes B; Shu HK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):469-76. PubMed ID: 23540347
[TBL] [Abstract][Full Text] [Related]
73. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.
Ding X; Mohd AB; Huang Z; Baba T; Bernardini MQ; Lyerly HK; Berchuck A; Murphy SK; Buermeyer AB; Devi GR
Br J Cancer; 2009 Jul; 101(2):269-77. PubMed ID: 19603033
[TBL] [Abstract][Full Text] [Related]
74. Anticancer effect of AZD2461 PARP inhibitor against colon cancer cells carrying wt or dysfunctional p53.
Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; Maretto M; Bassetti E; Caiazzo R; D'Orazi G; Cirone M
Exp Cell Res; 2021 Nov; 408(2):112879. PubMed ID: 34653407
[TBL] [Abstract][Full Text] [Related]
75. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.
Flanagan SA; Krokosky CM; Mannava S; Nikiforov MA; Shewach DS
Mol Pharmacol; 2008 Sep; 74(3):863-71. PubMed ID: 18535288
[TBL] [Abstract][Full Text] [Related]
76. Dclk1 Inhibition Cancels 5-FU-induced Cell-cycle Arrest and Decreases Cell Survival in Colorectal Cancer.
Suehiro Y; Takemoto Y; Nishimoto A; Ueno K; Shirasawa B; Tanaka T; Kugimiya N; Suga A; Harada E; Hamano K
Anticancer Res; 2018 Nov; 38(11):6225-6230. PubMed ID: 30396941
[TBL] [Abstract][Full Text] [Related]
77. Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
Fu Z; Regan K; Zhang L; Muders MH; Thibodeau SN; French A; Wu Y; Kaufmann SH; Lingle WL; Chen J; Tindall DJ
J Clin Invest; 2009 Sep; 119(9):2714-24. PubMed ID: 19690386
[TBL] [Abstract][Full Text] [Related]
78. Impact of MLH1 expression on tumor evolution after curative surgical tumor resection in a murine orthotopic xenograft model for human MSI colon cancer.
Meunier K; Ferron M; Calmel C; Fléjou JF; Pocard M; Praz F
Genes Chromosomes Cancer; 2017 Sep; 56(9):681-690. PubMed ID: 28512763
[TBL] [Abstract][Full Text] [Related]
79. A novel irinotecan derivative ZBH-1207 with different anti-tumor mechanism from CPT-11 against colon cancer cells.
Zhao D; Wu D; Zhang G; Li Y; Shi W; Zhong B; Yu H
Mol Biol Rep; 2022 Sep; 49(9):8359-8368. PubMed ID: 35764749
[TBL] [Abstract][Full Text] [Related]
80. DNA Topoisomerase I Gene Copy Number and mRNA Expression Assessed as Predictive Biomarkers for Adjuvant Irinotecan in Stage II/III Colon Cancer.
Nygård SB; Vainer B; Nielsen SL; Bosman F; Tejpar S; Roth A; Delorenzi M; Brünner N; Budinska E
Clin Cancer Res; 2016 Apr; 22(7):1621-31. PubMed ID: 26542057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
